A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)
Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
To define the effective dose and tolerability of levetiracetam in individuals with Restless
Legs Syndrome (RLS). It is hypothesized that levetiracetam will be well tolerated, safe and
effective in treating the symptoms of RLS.